Skip to main content
Log in

Haze-Bildung nach Vernetzungstherapie bei Keratokonus

Hazeformation (corneal scarring) after cross-linking therapy in keratoconus

  • Kasuistiken
  • Published:
Der Ophthalmologe Aims and scope Submit manuscript

Zusammenfassung

Ziel der Vernetzungsbehandlung ist die Verhinderung einer Progression des Keratokonus und die Stabilisierung des jetzigen Refraktionszustands. Bei einem 41-jährigen Patienten mit Keratokonus erfolgte eine einseitige kombinierte Riboflavin/UVA-Therapie. Postoperativ zeigte sich eine diffuse subepitheliale Trübung mit Anzeichen einer stromalen Verdünnung mittelperipher nasal unten. Diese oberflächliche Narbenbildung im Sinne eines „haze“ verschwand trotz intensiver Therapie nur zögerlich.

Abstract

The aim of cross-linking therapy is to prevent keratoconus progression and stabilize the present refractive situation. A 41-year-old man was treated with collagen cross-linking in one eye. Postoperatively there were a diffuse subepithelial opacification and a paracentral corneal thinning. This superficial scarring in the sense of a “haze” disappeared only gradually despite intensive therapy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Abb. 1
Abb. 2
Abb. 3

Literatur

  1. Braun E, Kanellopoulos J, Pe L et al. (2005) Riboflavin/ultraviolet A-induced collagen cross-linking in the management of keratoconus [abstract]. Invest Ophthalmol Vis Sci 46: 4964

    Google Scholar 

  2. Caporossi A, Biaocchi S, Mazotta C et al. (2006) Parasurgical therapy for keratoconus by riboflavin-ultraviolet type A rays induced cross-linking of corneal collagen – Preliminary refractive results in an Italian study. J Cataract Refract Surg 32: 837–845

    Article  PubMed  Google Scholar 

  3. Mazzotta C, Balestrazzi A, Traversi C et al. (2007) Treatment of progressive keratoconus by riboflavin-UVA-induced cross-linking of corneal collagen: ultrastructural analysis by Heidelberg Retinal Tomograph II in vivo confocal microscopy in humans. Cornea 26: 390–397

    Article  PubMed  Google Scholar 

  4. Mazzotta C, Traversi C, Baiocchi S et al. (2006) Conservative treatment of keratoconus by riboflavin-uva-induced cross-linking of corneal collagen: qualitative investigation. Eur J Ophthalmol 16: 530–535

    PubMed  CAS  Google Scholar 

  5. Sandner D, Spörl E, Kohlhaas M et al. (2004) Collagen cross-linking by combined Riboflavin/Ultraviolet A (UVA) treatment can stop the progression of keratoconus. Invest Ophthalmol Vis Sci [abstract] 45: E-abstract 2887

  6. Seiler T, Hafezi F (2006) Corneal cross-linking-induced stromal demarcation line. Cornea 25: 1057–1059

    Article  PubMed  Google Scholar 

  7. Wollensak G, Buddecke E (1990) Biomechanical studies on human corneal proteoglycans – a comparison of normal and keratoconic eyes. Graefes Arch Clin Exp Ophthalmol 228: 517–523

    Article  PubMed  CAS  Google Scholar 

  8. Wollensak G, Spörl E, Seiler T (2003) Behandlung von Keratokonus durch Kollagenvernetzung. Ophthalmologe 100: 44–49

    Article  PubMed  CAS  Google Scholar 

Download references

Interessenkonflikt

Keine Angaben

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to C.I.A. Herrmann.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Herrmann, C., Hammer, T. & Duncker, G. Haze-Bildung nach Vernetzungstherapie bei Keratokonus. Ophthalmologe 105, 485–487 (2008). https://doi.org/10.1007/s00347-007-1568-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00347-007-1568-z

Schlüsselwörter

Keywords

Navigation